These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12643395)

  • 1. Do left ventricular assist device (LVAD) bridge-to-transplantation outcomes predict the results of permanent LVAD implantation?
    Navia JL; McCarthy PM; Hoercher KJ; Feng J; Jeevantham R; Smedira NG; Banbury MK; Blackstone EH
    Ann Thorac Surg; 2002 Dec; 74(6):2051-62; discussion 2062-3. PubMed ID: 12643395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the type of ventricular assisted device influence survival, infection, and rejection rates following heart transplantation?
    Shuhaiber J; Hur K; Gibbons R
    J Card Surg; 2009; 24(3):250-5. PubMed ID: 19438776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study.
    El-Banayosy A; Arusoglu L; Kizner L; Tenderich G; Minami K; Inoue K; Körfer R
    J Thorac Cardiovasc Surg; 2000 Mar; 119(3):581-7. PubMed ID: 10694620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
    Kirsch L; Timmermans T; Van Caenegem O; Gurne O; Noirhomme P; Jacquet LM; Latinne D; Poncelet AJ
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application.
    McCarthy PM; Portner PM; Tobler HG; Starnes VA; Ramasamy N; Oyer PE
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):578-86; discussion 586-7. PubMed ID: 1921434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device.
    Siegenthaler MP; Martin J; Pernice K; Doenst T; Sorg S; Trummer G; Friesewinkel O; Beyersdorf F
    Eur J Cardiothorac Surg; 2003 May; 23(5):748-54; discussion 754-5. PubMed ID: 12754028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total artificial hearts: bridge to transplantation.
    Copeland JG; Arabia FA; Tsau PH; Nolan PE; McClellan D; Smith RG; Slepian MJ
    Cardiol Clin; 2003 Feb; 21(1):101-13. PubMed ID: 12790049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and healthcare expenditures in the real world with left ventricular assist devices - The CLEAR-LVAD study.
    Pagani FD; Mehra MR; Cowger JA; Horstmanshof DA; Silvestry SC; Atluri P; Cleveland JC; Lindenfeld J; Roberts GJ; Bharmi R; Dalal N; Kormos RL; Rogers JG
    J Heart Lung Transplant; 2021 May; 40(5):323-333. PubMed ID: 33744086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable left ventricular assist devices can successfully bridge adolescent patients to transplant.
    Helman DN; Addonizio LJ; Morales DL; Catanese KA; Flannery MA; Quagebeur JM; Edwards NM; Galantowicz ME; Oz MC
    J Heart Lung Transplant; 2000 Feb; 19(2):121-6. PubMed ID: 10703686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HeartMate left ventricular assist device as bridge to heart transplantation.
    Koul B; Solem JO; Steen S; Casimir-Ahn H; Granfeldt H; Lönn UJ
    Ann Thorac Surg; 1998 Jun; 65(6):1625-30. PubMed ID: 9647070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable left ventricular assist devices.
    Shinn JA
    J Cardiovasc Nurs; 2005; 20(5 Suppl):S22-30. PubMed ID: 16160581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.
    Kimura M; Kinoshita O; Nawata K; Nishimura T; Hatano M; Imamura T; Endo M; Kagami Y; Kubo H; Kashiwa K; Kinugawa K; Kyo S; Komuro I; Ono M
    J Cardiol; 2015 May; 65(5):383-9. PubMed ID: 25034705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?
    Klotz S; Stypmann J; Welp H; Schmid C; Drees G; Rukosujew A; Scheld HH
    Ann Thorac Surg; 2006 Nov; 82(5):1774-8. PubMed ID: 17062246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More than 20 years' experience of left ventricular assist device implantation at a non-transplant Centre.
    Holmberg E; Ahn H; Peterzén B
    Scand Cardiovasc J; 2017 Dec; 51(6):293-298. PubMed ID: 29029567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.